SECsense Logo

Regeneron Pharmaceuticals 8-K Report: Key Updates on August 1, 2025

$REGN
Form 8-K
Filed on: 2025-08-01
Source
Regeneron Pharmaceuticals 8-K Report: Key Updates on August 1, 2025

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: Regeneron Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0000872589
  • SEC File Number: 000-19034
  • EIN (Employer Identification Number): 13-3444607
  • Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
  • Contact Number: 914-847-7000
  1. Report Type:
  • Form Type: 8-K, which is used to report unscheduled material events or corporate changes that are of importance to shareholders.
  1. Report Date:
  • Date of Filing: August 1, 2025
  • Period Covered: The report covers a single day, August 1, 2025.
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share
  • Ticker Symbol: REGN
  • Exchange: NASDAQ

Insights:

  • This report is an 8-K filing indicating that Regeneron Pharmaceuticals may have disclosed significant events or changes that could impact shareholders or the market.
  • The single-day reporting period suggests that the information may pertain to a specific event or announcement that occurred on that date.
  • The par value of the common stock is relatively low, which is typical for many companies and does not directly reflect market value.

Conclusion:

The provided section contains essential identifiers and context for Regeneron Pharmaceuticals, highlighting its compliance with SEC reporting requirements and indicating a possible significant corporate event on August 1, 2025. Further details about the nature of the event would likely be found in the complete 8-K filing.